Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about PTGS2: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
The PTGS2 gene encodes cyclooxygenase-2 (COX-2), a key enzyme in prostaglandin synthesis that plays a critical role in neuroinflammation and neurodegenerative diseases including Alzheimer's, Parkinson's, and ALS.
No AI portrait yet
| Gene Symbol | PTGS2 |
| Full Name | Prostaglandin-Endoperoxide Synthase 2 |
| Aliases | COX-2 |
| Chromosome | 1q31.1 |
| Protein Family | prostaglandin synthase family |
| Protein Type | Enzyme |
| Function | encodes a key enzyme in the prostaglandin biosynthesis pathway that plays a pivotal role in neuroinflammation and neurodegenerative disease pathogenesis. |
| Primary Expression | Constitutive |
| Molecular Weight | 71 kDa |
| Exons | 10 |
| Pathways | NF-κB pathway, NF-κB, MAPK signaling, MAPK |
| UniProt ID | P35354 |
| NCBI Gene ID | 5743 |
| Ensembl ID | ENSG00000073756 |
| OMIM | 600262 |
| GeneCards | PTGS2 |
| Human Protein Atlas | PTGS2 |
| Associated Diseases | Aging, Als, Alzheimer, Cancer, Carcinoma |
| Interactions | ACSL4, ACTB, AKT, AKT1, AND, APOE |
| KG Connections | 709 knowledge graph edges |
| Databases | GeneCardsHPASTRING |
Knowledge base pages for this entity
graph TD
PTGS2["PTGS2"] -->|"Associated With"| Carcinoma["Carcinoma"]
PTGS2["PTGS2"] -->|"Associated With"| Tumor["Tumor"]
PTGS2["PTGS2"] -->|"Interacts With"| Ms["Ms"]
PTGS2["PTGS2"] -->|"Inhibits"| Cancer["Cancer"]
PTGS2["PTGS2"] -->|"Activates"| Fibrosis["Fibrosis"]
PTGS2["PTGS2"] -->|"Activates"| Als["Als"]
PTGS2["PTGS2"] -->|"Therapeutic Target"| Inflammation["Inflammation"]
PTGS2["PTGS2"] -->|"Therapeutic Target"| Stroke["Stroke"]
DZSM["DZSM"] -->|"Regulates"| PTGS2["PTGS2"]
SQSTM1["SQSTM1"] -->|"Associated With"| PTGS2["PTGS2"]
TNF["TNF"] -->|"Associated With"| PTGS2["PTGS2"]
ELAVL1["ELAVL1"] -->|"Associated With"| PTGS2["PTGS2"]
GPX4["GPX4"] -->|"Associated With"| PTGS2["PTGS2"]
style PTGS2 fill:#8d4900,color:#e0e0e0
style Carcinoma fill:#b71c1c,color:#e0e0e0
style Tumor fill:#b71c1c,color:#e0e0e0
style Ms fill:#b71c1c,color:#e0e0e0
style Cancer fill:#b71c1c,color:#e0e0e0
style Fibrosis fill:#b71c1c,color:#e0e0e0
style Als fill:#b71c1c,color:#e0e0e0
style Inflammation fill:#b71c1c,color:#e0e0e0
style Stroke fill:#b71c1c,color:#e0e0e0
style DZSM fill:#00838f,color:#e0e0e0
style SQSTM1 fill:#8d4900,color:#e0e0e0
style TNF fill:#8d4900,color:#e0e0e0
style ELAVL1 fill:#8d4900,color:#e0e0e0
style GPX4 fill:#8d4900,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| benchmark_ot_ad_answer_key:PTGS2 | data_in | dataset_row | 0.00 |
| benchmark_ot_ad_answer_key:PTGS2 | data_in | dataset_row | 0.00 |
| ds-83b31ef18d49 | provides_data_for | dataset | 1.00 |
| Cancer | therapeutic_target | disease | 1.00 |
| Als | therapeutic_target | disease | 0.95 |
| CANCER | therapeutic_target | gene | 0.90 |
| GENES | therapeutic_target | gene | 0.90 |
| ferroptosis | biomarker_for | process | 0.85 |
| Inflammation | therapeutic_target | disease | 0.85 |
| RAGE | therapeutic_target | gene | 0.80 |
| INFLAMMATION | therapeutic_target | gene | 0.80 |
| Aging | therapeutic_target | disease | 0.75 |
| Prostate Cancer | therapeutic_target | disease | 0.75 |
| Hepatitis | therapeutic_target | disease | 0.75 |
| Carcinoma | associated_with | disease | 0.75 |
| Atherosclerosis | therapeutic_target | disease | 0.75 |
| Fibrosis | therapeutic_target | disease | 0.75 |
| Neutrophilic Inflammation | involved_in | process | 0.75 |
| Cancer | inhibits | disease | 0.75 |
| Hepatocellular Carcinoma | associated_with | disease | 0.75 |
| AKT | therapeutic_target | gene | 0.70 |
| Autophagy | associated_with | pathway | 0.70 |
| MMP9 | expressed_in | gene | 0.70 |
| MMP9 | therapeutic_target | gene | 0.70 |
| IL-6 | therapeutic_target | gene | 0.70 |
| TNF-Α | therapeutic_target | gene | 0.70 |
| Apoptosis | therapeutic_target | pathway | 0.70 |
| Mapk | therapeutic_target | pathway | 0.70 |
| CASP3 | therapeutic_target | gene | 0.70 |
| Cardiovascular | interacts_with | disease | 0.65 |
| Diabetes | therapeutic_target | disease | 0.65 |
| Cancer | associated_with | disease | 0.65 |
| Cardiovascular | regulates | disease | 0.65 |
| Aging | protects_against | disease | 0.65 |
| Alzheimer | protects_against | disease | 0.65 |
| Cancer | protects_against | disease | 0.65 |
| Atherosclerosis | interacts_with | disease | 0.65 |
| Als | associated_with | disease | 0.65 |
| ALS | associated_with | disease | 0.65 |
| ALS | protects_against | disease | 0.65 |
| Als | interacts_with | disease | 0.65 |
| Cardiac | regulates | disease | 0.65 |
| Ms | therapeutic_target | disease | 0.65 |
| Ms | regulates | disease | 0.65 |
| Fibrosis | associated_with | disease | 0.65 |
| Rheumatoid Arthritis | therapeutic_target | disease | 0.65 |
| Fibrosis | inhibits | disease | 0.65 |
| Cardiac | activates | disease | 0.65 |
| Gastric Cancer | therapeutic_target | disease | 0.65 |
| Obesity | therapeutic_target | disease | 0.65 |
| Source | Relation | Type | Str |
|---|---|---|---|
| benchmark_ot_ad_answer_key:PTGS2 | data_in | dataset_row | 0.00 |
| benchmark_ot_ad_answer_key:PTGS2 | data_in | dataset_row | 0.00 |
| TMEM16F | regulates | gene | 1.00 |
| ds-83b31ef18d49 | data_in | dataset | 1.00 |
| Hesperetin | regulates | drug | 0.90 |
| SQSTM1 | associated_with | gene | 0.70 |
| GPX4 | associated_with | gene | 0.70 |
| ELAVL1 | associated_with | gene | 0.70 |
| IL6 | interacts_with | gene | 0.70 |
| OXIDATIVE STRESS | therapeutic_target | gene | 0.70 |
| ROS | associated_with | gene | 0.70 |
| TP53 | therapeutic_target | gene | 0.70 |
| ATG | associated_with | gene | 0.70 |
| P62 | associated_with | gene | 0.70 |
| FTH1 | associated_with | gene | 0.70 |
| GENES | therapeutic_target | gene | 0.70 |
| TNF | associated_with | gene | 0.70 |
| BECN1 | associated_with | gene | 0.70 |
| DZSM | regulates | drug | 0.70 |
| COL1A1 | associated_with | gene | 0.70 |
| TNF | therapeutic_target | gene | 0.70 |
| AUTOPHAGY | associated_with | gene | 0.70 |
| P53 | therapeutic_target | gene | 0.70 |
| TP53 | associated_with | gene | 0.70 |
| PI3K | therapeutic_target | gene | 0.70 |
| JUN | associated_with | gene | 0.70 |
| NCOA4 | associated_with | gene | 0.70 |
| IL6 | therapeutic_target | gene | 0.60 |
| MMP9 | therapeutic_target | gene | 0.60 |
| TP53 | interacts_with | gene | 0.60 |
| ICAM1 | expressed_in | gene | 0.60 |
| MMP9 | expressed_in | gene | 0.60 |
| CD4 | therapeutic_target | gene | 0.60 |
| AKT1 | associated_with | gene | 0.60 |
| FOS | associated_with | gene | 0.60 |
| MAPK1 | associated_with | gene | 0.60 |
| MMP9 | associated_with | gene | 0.60 |
| RELA | associated_with | gene | 0.60 |
| MYC | associated_with | gene | 0.60 |
| EGF | associated_with | gene | 0.60 |
| BNIP3L | therapeutic_target | gene | 0.60 |
| CASP3 | associated_with | gene | 0.60 |
| UBIQUITIN | interacts_with | gene | 0.60 |
| MMP3 | associated_with | gene | 0.60 |
| STAT3 | associated_with | gene | 0.60 |
| SLC7A11 | inhibits | gene | 0.60 |
| GPX4 | inhibits | gene | 0.60 |
| JNK | inhibits | gene | 0.60 |
| BCL2 | therapeutic_target | gene | 0.60 |
| IL6 | associated_with | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity